HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Konstantinos Markakis Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pantos, C. Articles by Cokkinos, D. V. Search for Related Content PubMed PubMed Citation Articles by Pantos, C. Articles by Cokkinos, D. V. Related Collections Cardiac - pharmacology Cardiac - physiology Congestive Heart Failure Myocardial infarction

Eur J Cardiothorac Surg 2007;32:333-339. doi:10.1016/j.ejcts.2007.05.004
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats

^a Department of Pharmacology, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Athens, Greece
^b 1^st Cardiology Department, Onassis Cardiac Surgery Center, 356 Sygrou Avenue, 176 74 Kallithea, Athens, Greece

Received 13 November 2006; received in revised form 5 March 2007; accepted 9 May 2007.

^_* Corresponding author. Address: Department of Pharmacology, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Athens, Greece. Fax: +30 210 7462560. (Email: cpantos{at}cc.uoa.gr).

Objective: Cardiac remodeling of viable myocardium occurs after acute myocardial infarction (AMI) and further contributes to cardiac dysfunction. The present study explored whether thyroid hormone (TH) administered shortly after AMI in rats can attenuate cardiac remodeling and improve cardiac function. TH regulates important structural and regulatory proteins in the myocardium including myosin isoform expression and calcium cycling proteins. Methods: AMI was induced in Wistar male rats by ligating left coronary artery (AMI, n = 10), while sham-operated rats were used as controls (SHAM, n = 10). Animals with acute myocardial infarction were also treated with 0.05% thyroid powder in food (AMI-THYR, n = 10). Within 2 weeks, cardiac function was impaired as assessed by echocardiography and under isometric conditions in Langendorff preparations. Results: Ejection fraction (EF%) was 71.5 (SEM, 2.7) in SHAM versus 30.0 (2.0) in AMI, P < 0.05. +dp/dt was 3886 (566) in SHAM versus 2266 (206) in AMI hearts, P < 0.05 and –dp/dt was 1860 (46) in SHAM versus 1633 (120) in AMI hearts, P = ns. Such changes were associated with alterations in myosin isoform expression in the non-infarcted area; AMI hearts expressed 34% -MHC and 66% ß-MHC versus 52% -MHC and 48% ß-MHC in SHAM, P < 0.05, while the expression of SERCA and phospholamban (PLB) remained unchanged. Furthermore, a mismatch of left ventricular size and cardiac mass (2*Posterior Wall thickness/LVIDd was decreased) was observed. After TH treatment, AMI-THYR hearts expressed 71% -MHC and 29% ß-MHC, P < 0.05 versus SHAM and AMI and the ratio of SERCA/PLB was increased by 2.0-fold, P < 0.05 versus SHAM and AMI. These changes corresponded to a marked improvement in cardiac function; EF% was raised to 45.8 (1.7), P < 0.05 versus AMI while +dp/dt and –dp/dt were 3800 (435) and 2600 (200), respectively, in AMI-THYR hearts, P < 0.05 versus AMI. The ratio of 2*Posterior Wall thickness/LVIDd was normalized. Conclusions: Thyroid hormone administration early after infarction attenuates cardiac remodeling and significantly improves myocardial performance.

Key Words: Thyroid hormone • Acute myocardial infarction • Cardiac remodeling • Myosin • PKC • Thyroid hormone receptors